Projects per year
Search results
-
Active
Early Detection of Hepatocellular Carcinoma - Renewal Submission
4/21/22 → 2/28/27
Project: Federal Funding Agencies
-
The Effect of Semaglutide in Subjects with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH)
Victor, III, D. W., Kodali, S. & Shetty, A.
2/25/22 → …
Project: Clinical Trial
-
A Randomized, Double-blind, Placebo-controlled, Phase 2b study to Evaluate Safety and Efficacy of DUR-928 in Subjects with Alcoholic Hepatitis
Victor, III, D. W., Kodali, S., Mobley, C. M. & Shetty, A.
10/5/21 → …
Project: Clinical Trial
-
A Study to Test Safety and Efficacy of BI456906 in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
Victor, III, D. W., Kodali, S. & Shetty, A.
9/15/21 → …
Project: Clinical Trial
-
LIVERFASt Clinical performance evaluation of the LIVERFASt Tests to determine fibrosis staging, inflammatory activity and steatosis grading compared with Liver Biopsy in patients with metabolic factors and presumed Non-Alcoholic Fatty Liver Disease (NAFLD)
Kodali, S. & Victor, III, D. W.
8/18/21 → …
Project: Clinical Trial
-
LEAP-012 - MERCK (7902-012, Site No. 0784) Safety and Efficacy of Lenvatinib (E7080 / MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable / Non-metastatic Hepatocellular Carcinoma (MK-7902-012 / E7080-G000-318 / LEAP-012)
Kodali, S., Abdelrahim, M., Ghobrial, R. M., Gibbs, J. M., Heyne, K., Saharia, A., Shetty, A. & Victor, III, D. W.
3/27/20 → …
Project: Clinical Trial
-
Mild Hypothermia and Acute Kidney Injury AKI in Liver Transplantation MHALT Trial
Ghobrial, R. M., Lindberg, S., Mobley, C. M., Saharia, A. & Victor, III, D. W.
2/10/20 → …
Project: Clinical Trial
-
Ultra High-Field MR Spectroscopy of Non-alcoholic fatty liver disease
Victor, III, D. W., Ghobrial, R. M., Graviss, E. A., Gupta, N. & Karmonik, C.
1/30/20 → …
Project: Clinical Trial
-
Zortress® (everolimus) and Myfortic® (enteric-coated mycophenolate sodium) for the Reduction of Calcineurin Inhibitors and Protection of Kidney Function and Abrogation of Chronic Rejection in Liver Transplantation (CRAD001HUS192C) (PO# 3004203722)
Ghobrial, R. M., Hobeika, M. J., Ibrahim, H. N., Mobley, C. M., Moore, L. W., Saharia, A. & Victor, III, D. W.
12/6/19 → …
Project: Clinical Trial
-
Resubmission_R01_Subcontract_MD Anderson-Early Detection of Hepatocellular Carcinoma
2/19/19 → …
Project: Clinical Trial
-
Not started
OCS Liver PROTECT CAP Trial
Saharia, A., Ghobrial, R. M., Hobeika, M. J., Mobley, C. M. & Victor, III, D. W.
Project: Clinical Trial
-
A randomized, double-blind, placebo-controlled, multicenter, Phase 3 study evaluating long-term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2/fibrosis 3 stage of liver fibrosis
Victor, III, D. W., Kodali, S. & Shetty, A.
Project: Clinical Trial
-
A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Subjects With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
Victor, III, D. W. & Kodali, S.
Project: Clinical Trial
-
Finished